Perspective
Biden’s Hepatitis C Initiative Needs Help from the Private Market
December 9, 2023
Featured Experts: Dana Goldman, PhD
Research
All Research Featured Research
Perspective
Congress Can Eradicate Hepatitis C and Reduce the Deficit at the Same Time
July 14, 2023
Featured Experts: Neeraj Sood, PhD
Journal Article
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative
April 20, 2023
Featured Experts: Neeraj Sood, PhD
Journal Article
Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis
April 27, 2022
Featured Experts: William Padula, PhD
News
USC Study Finds When Medicare Chips in for Hepatitis C Treatment for Medicaid Patients, Everyone Wins
May 20, 2021
Featured Experts: William Padula, PhD
Journal Article
Cost- Effectiveness of Total State Coverage for Hepatitis C Medications
May 20, 2021
Featured Experts: William Padula, PhD
Evidence Base
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
February 28, 2019
Featured Experts: Neeraj Sood, PhD
Journal Article
A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C
February 5, 2019
Featured Experts: Rosalie Liccardo Pacula, PhD
Perspective
When We Find a Cure, Price it Like Netflix to Ensure Access
August 13, 2018
Featured Experts: Dana Goldman, PhD
Perspective
New Payment Strategy Could Help States Treat More Hepatitis C Patients While Encouraging Innovation
May 15, 2018
Featured Experts: Neeraj Sood, PhD
White Paper
Policy Brief: A Novel Strategy for Increasing Access to Hep C Treatment for Medicaid Beneficiaries
May 15, 2018
Featured Experts: Neeraj Sood, PhD
News
How States Could Be Saving More Hepatitis C Patients
May 15, 2018
Featured Experts: Neeraj Sood, PhD
Perspective
Here’s How We Can Increase the Supply of Organs and Keep People off of the Waiting List
February 12, 2018
Featured Experts: Dana Goldman, PhD
Perspective
A Good Deal For Eliminating Hepatitis C: Saving Money And Lives
April 24, 2017
Featured Experts: Neeraj Sood, PhD
Journal Article
Costs and Spillover Effects of Private Insurers’ Coverage of Hepatitis C Treatment
May 1, 2016
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Journal Article
Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A Concern
October 31, 2015
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD